SynthesisJournal of diabetes investigation2023

Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.

Katsuhiko Hagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.